(Q40863632)

24 September 2017

title

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro (English)

1 reference

24 September 2017

vaccinia virus

1 reference

inferred from title

author

Geoffrey Lilley Smith

6

object named as

Smith GL

1 reference

24 September 2017

Dorrell L

1

1 reference

24 September 2017

O'Callaghan CA

2

1 reference

24 September 2017

Britton W

3

1 reference

24 September 2017

Hambleton S

4

1 reference

24 September 2017

McMichael A

5

1 reference

24 September 2017

Rowland-Jones S

7

1 reference

24 September 2017

Blanchard TJ

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

2-3

1 reference

24 September 2017

page(s)

327-336

1 reference

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Expression of the HTLV-III envelope gene by a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Rapid effector function in CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

1 reference

7 January 2021

Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900135-3

7 January 2021

10.1016/S0264-410X(00)00135-3

Identifiers

DOI

1 reference

24 September 2017

1 reference